1. Home
  2. CPRX
  3. CPRX News

Latest Catalyst Pharmaceuticals Inc. (CPRX) News on December 18, 2024

Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CPRX

GlobeNewswire

2 days ago

Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NewAmsterdam Pharma Stock Hits 90-Plus RS Rating
CPRX

Investor's Business Daily

7 days ago

NewAmsterdam Pharma Stock Hits 90-Plus RS Rating

CPRX

Argus Research

8 days ago

CPRX: What does Argus have to say about CPRX?

Why Is Catalyst (CPRX) Down 6.7% Since Last Earnings Report?
CPRX

Zacks

12 days ago

Why Is Catalyst (CPRX) Down 6.7% Since Last Earnings Report?

CPRX

Argus Research

15 days ago

CPRX: What does Argus have to say about CPRX?

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
CPRX

Simply Wall St.

15 days ago

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term
CPRX

Zacks

16 days ago

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
CPRX

Zacks

21 days ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List
CPRX

GlobeNewswire

23 days ago

Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
CPRX

GlobeNewswire

a month ago

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
CPRX

Zacks

a month ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work
CPRX

GlobeNewswire

a month ago

Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work

Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings May Just Be The Starting Point
CPRX

Simply Wall St.

a month ago

Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings May Just Be The Starting Point

CPRX

Argus Research

a month ago

CPRX: Raising target price to $24.00

Vericel Stock Sees RS Rating Shoot Higher
CPRX

Investor's Business Daily

a month ago

Vericel Stock Sees RS Rating Shoot Higher

Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
CPRX

GuruFocus.com

a month ago

Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Makes An Interesting Case
CPRX

Simply Wall St.

a month ago

With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Makes An Interesting Case

Catalyst Pharmaceuticals, Inc. (CPRX) Hit a 52 Week High, Can the Run Continue?
CPRX

Zacks

a month ago

Catalyst Pharmaceuticals, Inc. (CPRX) Hit a 52 Week High, Can the Run Continue?

Catalyst (CPRX) Reports Q3 Earnings: What Key Metrics Have to Say
CPRX

Zacks

a month ago

Catalyst (CPRX) Reports Q3 Earnings: What Key Metrics Have to Say

Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates
CPRX

Zacks

a month ago

Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates

CPRX

Associated Press Finance

a month ago

Catalyst: Q3 Earnings Snapshot

Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update
CPRX

GlobeNewswire

a month ago

Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

CPRX vs. STVN: Which Stock Is the Better Value Option?
CPRX

Zacks

a month ago

CPRX vs. STVN: Which Stock Is the Better Value Option?

Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Report Preview: What To Look For
CPRX

GuruFocus.com

a month ago

Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Report Preview: What To Look For

CPRX

Argus Research

a month ago

CPRX: What does Argus have to say about CPRX?

Are Medical Stocks Lagging Bioventus (BVS) This Year?
CPRX

Zacks

a month ago

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024
CPRX

GlobeNewswire

2 months ago

Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

CPRX or STVN: Which Is the Better Value Stock Right Now?
CPRX

Zacks

2 months ago

CPRX or STVN: Which Is the Better Value Stock Right Now?

High Growth Tech Stocks to Watch in October 2024
CPRX

Simply Wall St.

2 months ago

High Growth Tech Stocks to Watch in October 2024

With 75% ownership of the shares, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is heavily dominated by institutional owners
CPRX

Simply Wall St.

2 months ago

With 75% ownership of the shares, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is heavily dominated by institutional owners

CPRX

Argus Research

2 months ago

CPRX: What does Argus have to say about CPRX?

Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts
CPRX

GlobeNewswire

2 months ago

Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts

CPRX or STVN: Which Is the Better Value Stock Right Now?
CPRX

Zacks

2 months ago

CPRX or STVN: Which Is the Better Value Stock Right Now?

Catalyst (CPRX) Upgraded to Buy: What Does It Mean for the Stock?
CPRX

Zacks

3 months ago

Catalyst (CPRX) Upgraded to Buy: What Does It Mean for the Stock?

Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024
CPRX

GlobeNewswire

3 months ago

Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan
CPRX

GlobeNewswire

3 months ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan

High Growth Tech Stocks In The United States You Should Know
CPRX

Simply Wall St.

3 months ago

High Growth Tech Stocks In The United States You Should Know

Despite lower earnings than three years ago, Catalyst Pharmaceuticals (NASDAQ:CPRX) investors are up 293% since then
CPRX

Simply Wall St.

3 months ago

Despite lower earnings than three years ago, Catalyst Pharmaceuticals (NASDAQ:CPRX) investors are up 293% since then

Why Is Catalyst (CPRX) Up 8.3% Since Last Earnings Report?
CPRX

Zacks

3 months ago

Why Is Catalyst (CPRX) Up 8.3% Since Last Earnings Report?

Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today
CPRX

Zacks

4 months ago

Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today

CPRX

Argus Research

4 months ago

CPRX: Lowering target price to $21.00

CPRX

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 08/23/2024

Insider Sale at Catalyst Pharmaceuticals Inc (CPRX): Chief Operating & Scientific Officer ...
CPRX

GuruFocus.com

4 months ago

Insider Sale at Catalyst Pharmaceuticals Inc (CPRX): Chief Operating & Scientific Officer ...

CPRX

Argus Research

4 months ago

CPRX: Raising target price to $22.00

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
CPRX

GlobeNewswire

4 months ago

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

Here's How Much You'd Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago
CPRX

Zacks

4 months ago

Here's How Much You'd Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago

Wall Street Analysts See a 56.65% Upside in Catalyst (CPRX): Can the Stock Really Move This High?
CPRX

Zacks

4 months ago

Wall Street Analysts See a 56.65% Upside in Catalyst (CPRX): Can the Stock Really Move This High?

Catalyst Pharmaceuticals' (NASDAQ:CPRX) Anemic Earnings Might Be Worse Than You Think
CPRX

Simply Wall St.

4 months ago

Catalyst Pharmaceuticals' (NASDAQ:CPRX) Anemic Earnings Might Be Worse Than You Think

Catalyst (CPRX) Reports Q2 Earnings: What Key Metrics Have to Say
CPRX

Zacks

4 months ago

Catalyst (CPRX) Reports Q2 Earnings: What Key Metrics Have to Say

Catalyst Pharmaceutical (CPRX) Beats Q2 Earnings and Revenue Estimates
CPRX

Zacks

4 months ago

Catalyst Pharmaceutical (CPRX) Beats Q2 Earnings and Revenue Estimates

CPRX

Associated Press Finance

4 months ago

Catalyst: Q2 Earnings Snapshot

Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update
CPRX

GlobeNewswire

4 months ago

Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update

Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada
CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada

CPRX

Argus Research

5 months ago

CPRX: What does Argus have to say about CPRX?

Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024

CPRX

Argus Research

5 months ago

CPRX: Raising target price to $18.00

CPRX

Argus Research

5 months ago

CPRX: Lowering target price to $16.00

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
CPRX

GuruFocus.com

6 months ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

CPRX

Energy Global

6 months ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
CPRX

USA TODAY

6 months ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management
CPRX

Business Wire

6 months ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins
CPRX

Business Wire

6 months ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

SEALSQ to Launch Two New Quantum Resistant Chips
CPRX

GlobeNewswire

6 months ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll
CPRX

Reuters

6 months ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030
CPRX

GlobeNewswire

6 months ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)
CPRX

GuruFocus.com

6 months ago

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
CPRX

GlobeNewswire

6 months ago

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

ThreeD Capital Inc. Announces Unaudited May 31, 2024 Net Asset Value Per Share - $0.72
CPRX

GlobeNewswire

6 months ago

ThreeD Capital Inc. Announces Unaudited May 31, 2024 Net Asset Value Per Share - $0.72

Camber Energy Announces Passing of Director Lawrence Fisher
CPRX

ACCESSWIRE

6 months ago

Camber Energy Announces Passing of Director Lawrence Fisher

Ciscom Corp. to Hold Annual and Special Meeting of the Shareholders on August 20, 2024
CPRX

Newsfile

6 months ago

Ciscom Corp. to Hold Annual and Special Meeting of the Shareholders on August 20, 2024

CORUS PROVIDES UPDATE ON PROGRAMMING AND TRADEMARK OUTPUT ARRANGEMENTS
CPRX

CNW Group

6 months ago

CORUS PROVIDES UPDATE ON PROGRAMMING AND TRADEMARK OUTPUT ARRANGEMENTS

CPRX

GlobeNewswire

6 months ago

NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Filing of Annual Report on Form 10-Q

Media Advisory - Prime Minister's itinerary for Saturday, June 8, 2024
CPRX

CNW Group

6 months ago

Media Advisory - Prime Minister's itinerary for Saturday, June 8, 2024

Why Is Catalyst (CPRX) Up 0.7% Since Last Earnings Report?
CPRX

Zacks

6 months ago

Why Is Catalyst (CPRX) Up 0.7% Since Last Earnings Report?

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong Financials Guiding The Market?
CPRX

Simply Wall St.

6 months ago

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong Financials Guiding The Market?

Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
CPRX

GlobeNewswire

7 months ago

Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®

Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
CPRX

GlobeNewswire

7 months ago

Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024

2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
CPRX

Motley Fool

7 months ago

2 Incredible Growth Stocks to Buy Hand Over Fist Right Now

CPRX

Associated Press Finance

7 months ago

Catalyst: Q1 Earnings Snapshot

Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
CPRX

GlobeNewswire

7 months ago

Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CPRX

Zacks

8 months ago

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
CPRX

Zacks

8 months ago

Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth

Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024
CPRX

GlobeNewswire

8 months ago

Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024

CPRX

Argus Research

8 months ago

CPRX: Lowering target price to $15.00

Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
CPRX

GlobeNewswire

8 months ago

Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who own 65% of the company
CPRX

Simply Wall St.

8 months ago

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who own 65% of the company

Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
CPRX

Insider Monkey

8 months ago

Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024

Why Is Catalyst (CPRX) Down 0.6% Since Last Earnings Report?
CPRX

Zacks

9 months ago

Why Is Catalyst (CPRX) Down 0.6% Since Last Earnings Report?

Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
CPRX

GlobeNewswire

9 months ago

Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day

Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
CPRX

GlobeNewswire

9 months ago

Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium

Investors in Catalyst Pharmaceuticals (NASDAQ:CPRX) have seen strong returns of 271% over the past three years
CPRX

Simply Wall St.

9 months ago

Investors in Catalyst Pharmaceuticals (NASDAQ:CPRX) have seen strong returns of 271% over the past three years

Crinetics Pharmaceuticals (CRNX) Stock Jumps 19.1%: Will It Continue to Soar?
CPRX

Zacks

9 months ago

Crinetics Pharmaceuticals (CRNX) Stock Jumps 19.1%: Will It Continue to Soar?

Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
CPRX

GlobeNewswire

9 months ago

Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)

Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
CPRX

GlobeNewswire

9 months ago

Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference

Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates
CPRX

Zacks

10 months ago

Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates

CPRX

Associated Press Finance

10 months ago

Catalyst: Q4 Earnings Snapshot

Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
CPRX

GlobeNewswire

10 months ago

Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE
CPRX

GlobeNewswire

10 months ago

Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE

Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology
CPRX

GlobeNewswire

10 months ago

Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
CPRX

GlobeNewswire

10 months ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

Share on Social Networks: